- What is Agate Medical Investments' primary investment focus?
- Agate Medical Investments LP specializes in providing growth capital to mature medtech companies, focusing on innovations in diagnostics, prevention, and treatment of serious illnesses.
- Which investment stages does Agate Medical Investments typically participate in?
- Agate Medical Investments participates in a range of investment stages, including A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
- Can you name a notable exit for Agate Medical Investments?
- Agate Medical Investments saw an exit in December 2021 with Epitomee Medical, which went public on TASE with a valuation of $203M.
- What was another significant exit for Agate Medical Investments?
- In September 2018, Agate Medical Investments had an exit when MST - Medical Surgery Technologies was acquired by Asensus for $34M.
- Which portfolio companies are currently in Agate Medical Investments' portfolio?
- Agate Medical Investments' portfolio includes companies such as BrainsGate, which has raised $98.5M, and CLEW, which has raised $20.5M.
- What is Agate Medical Investments' geographic focus?
- Agate Medical Investments is based in Tel Aviv-Yafo, Israel, and established a bi-national Israeli-Korean fund in February 2012 in partnership with the MAC fund for Korea-Israel medtech investments.
- Who are the key personnel at Agate Medical Investments?
- The key personnel at Agate Medical Investments include Dani Naveh, Founder, Ami H. Orkaby, Managing Partner, and Ariel Moses, Managing General Partner.
- What is Agate Medical Investments' strategy regarding exit potential?
- Agate Medical Investments focuses on select mature companies seeking a final round or buyout financing to maximize their exit-value potential, with a clear exit strategy validated by fund managers.